HLA-B27 expression does not modulate intracellular Chlamydia trachomatis infection of cell lines.
Chlamydia trachomatis is an obligate intracellular pathogen. Infection of susceptible individuals with this bacterium can trigger the development of reactive arthritis, an acute inflammation that is associated with the expression of the class I major histocompatibility antigen, HLA-B27. Other facultative intracellular pathogens, such as Yersinia and Salmonella spp., are also known triggers of reactive arthritis. Previous studies report conflicting results concerning whether the presence of HLA-B27 modulates the infection of cells with these enteric pathogens. In the present study, we have examined whether the expression of HLA-B27 can influence the infection of cell lines with C. trachomatis and also whether the replication of these bacteria is altered in HLA-B27-expressing cell lines. To do this, we have used a sensitive flow cytometric approach. We fixed and permeabilized cells and used fluorescein isothiocyanate-conjugated monoclonal antibody specific for chlamydia lipopolysaccharide to detect intracellular bacteria. The staining pattern obtained closely resembled the intracellular life cycle of chlamydia, with the appearance of brightly staining cells correlating to the microscopic detection of mature inclusion bodies. Moreover, since the percentage of cells that stained with the antibody was proportional to the infectious inoculum used, we were able to use the technique to quantitate the number of infectious organisms recoverable from infected cell lines. An important component of our study was the use of heparin to prevent reinfection of cells and thus enable the infection to be followed from a discrete time point. Our results suggest that HLA-B27 influences neither the infection nor replication of C. trachomatis serovar L2 within cell lines. Consequently, the role of HLA-B27 in the pathogenesis of reactive arthritis may lie downstream of the invasion and replication stages of the triggering pathogenic infection.
Young
J L
JL
Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital, Cambridge CB2 2QQ, United Kingdom. jly21@medschl.cam.ac.uk
Smith
L
L
Matyszak
M K
MK
Gaston
J S
JS
D002460:Cell Line; D002690:Chlamydia Infections / Q000276:immunology*; D002692:Chlamydia trachomatis / Q000187:drug effects / Q000254:growth & development / Q000276:immunology*; D015870:Gene Expression; D015796:HLA-B27 Antigen / Q000235:genetics / Q000276:immunology*; D006367:HeLa Cells; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D007424:Intracellular Fluid / Q000382:microbiology
D015796:HLA-B27 Antigen; D006493:Heparin